Busting the breast cancer with astrazeneca's gefinitib

• Main Authors: Chemmalar, S., Intan Shameha, A. R., Che Abdullah, Che Azurahanim, Ab Razak, Nor Asma, Mohamad Yusof, Loqman, Ajat, Mokrish, Chan, Kim Wei, Abu Bakar Zakaria, Md Zuki
• Format: Article
• Language: English
• Published: Wiley Open Access 2023
• Online Access: http://psasir.upm.edu.my/id/eprint/106928/1/Busting%20the%20breast%20cancer%20with%20astrazeneca%27s%20gefinitib.pdf; http://psasir.upm.edu.my/id/eprint/106928/; https://www.hindawi.com/journals/aps/2023/8127695/
• Institution: Universiti Putra Malaysia

Breast cancer is the most common cancer diagnosed in women, and in 2020, there were 684, 996 deaths due to this disease. Epidermal growth factor receptors (EGFRs) and their respective ligands have been blamed for the pathogenesis and resistance to treatment in specific breast cancer cases. With EGFR...